Marc Cobo
At a glance: Marc Cobo is Principal Accounting Officer at BridgeBio Oncology Therapeutics (BBOT). Their latest SEC Form 4, filed Nov 17, 2026, reported a sale of $185. On file: 0 purchase lines ($0) and 1 sale line ($185).
Disclosed holdings: about $25K of BBOT stock: 13,734 shares reported on their latest Form 4 (filed Nov 17, 2026), valued at the Nov 20, 2026 close of $1.82. This counts only BBOT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 17SEC | BBOTBridgeBio Oncology Therapeutics, Inc. | Sell Plan | 7813,734 held (−1%) | $2.37 | $185 | -23.2% |
- Sell
Principal Accounting Officer Marc Cobo sold $185 of BBOT at $2.37 — pre-scheduled 10b5-1 plan sale.
Follow Marc Cobo
Get one email when Marc Cobo files a new purchase or sale. Free.
At most one email a day about Marc Cobo, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.